RxDoctor Payments Data

Patrick Johnston, MD

Hematology · Rochester, MNNPI 1053399246

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology clinicians in MN, where the typical reported total is $422.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$7,358,500in research payments, 2019–2025

Across 313 payments — averaging $23,510 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Beigene, Ltd.$4.5M
  • Bristol Myers Squibb$1.1M
  • Beone Medicines Ltd.$675K
  • Novartis$476K
  • Gilead$248K
  • Takeda Pharmaceuticals U.S.A., Inc.$96K
  • plus $321K from 7 others

How this compares

$0 in reported general payments places this provider in the 15th percentile of 111 hematology providers in Minnesota.

See all hematology providers in Minnesota

Medicare billing

Part B allowed, 2024
$294,681
Medicare patients
186
Services billed
20,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acyclovir24$187
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$168

Paid to pharmacies, not to this prescriber.

Other hematology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →